Annual EBIT
-$49.33 M
-$4.25 M-9.43%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual earnings before interest & taxes is -$49.33 million, with the most recent change of -$4.25 million (-9.43%) on December 31, 2023.
- During the last 3 years, HEPA annual EBIT has fallen by -$29.03 million (-143.08%).
- HEPA annual EBIT is now -2849.92% below its all-time high of -$1.67 million, reached on June 30, 2014.
Performance
HEPA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.46 M
+$4.05 M+47.57%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly earnings before interest & taxes is -$4.46 million, with the most recent change of +$4.05 million (+47.57%) on September 30, 2024.
- Over the past year, HEPA quarterly EBIT has increased by +$6.21 million (+58.20%).
- HEPA quarterly EBIT is now -174.85% below its all-time high of $5.96 million, reached on March 1, 2009.
Performance
HEPA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$30.07 M
+$6.21 M+17.11%
September 30, 2024
Summary
- As of February 7, 2025, HEPA TTM earnings before interest & taxes is -$30.07 million, with the most recent change of +$6.21 million (+17.11%) on September 30, 2024.
- Over the past year, HEPA TTM EBIT has increased by +$19.25 million (+39.03%).
- HEPA TTM EBIT is now -272.60% below its all-time high of $17.42 million, reached on December 1, 2009.
Performance
HEPA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
HEPA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.4% | +58.2% | +39.0% |
| 3 y3 years | -143.1% | +54.1% | +8.1% |
| 5 y5 years | -411.4% | +54.1% | +8.1% |
HEPA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.8% | at low | at high | +77.6% | at high | +43.1% |
| 5 y | 5-year | -567.4% | at low | -106.3% | +77.6% | -306.8% | +43.1% |
| alltime | all time | -2849.9% | at low | -174.8% | +77.6% | -272.6% | +43.1% |
Hepion Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.46 M(-47.6%) | -$30.07 M(-17.1%) |
| Jun 2024 | - | -$8.50 M(+46.1%) | -$36.27 M(-13.5%) |
| Mar 2024 | - | -$5.82 M(-48.4%) | -$41.94 M(-15.1%) |
| Dec 2023 | -$49.33 M(+9.4%) | -$11.29 M(+5.8%) | -$49.37 M(+0.1%) |
| Sep 2023 | - | -$10.66 M(-24.7%) | -$49.32 M(+4.7%) |
| Jun 2023 | - | -$14.17 M(+6.8%) | -$47.12 M(-10.9%) |
| Mar 2023 | - | -$13.26 M(+18.1%) | -$52.86 M(+13.6%) |
| Dec 2022 | -$45.07 M(+37.8%) | -$11.23 M(+32.6%) | -$46.53 M(+3.4%) |
| Sep 2022 | - | -$8.47 M(-57.5%) | -$45.02 M(-1.8%) |
| Jun 2022 | - | -$19.91 M(+187.4%) | -$45.82 M(+36.5%) |
| Mar 2022 | - | -$6.93 M(-28.7%) | -$33.58 M(+2.6%) |
| Dec 2021 | -$32.71 M(+61.2%) | -$9.72 M(+4.9%) | -$32.71 M(+17.1%) |
| Sep 2021 | - | -$9.27 M(+20.9%) | -$27.94 M(+12.0%) |
| Jun 2021 | - | -$7.66 M(+26.4%) | -$24.95 M(+12.7%) |
| Mar 2021 | - | -$6.06 M(+22.6%) | -$22.13 M(+9.0%) |
| Dec 2020 | -$20.29 M(+174.6%) | -$4.94 M(-21.2%) | -$20.29 M(+15.9%) |
| Sep 2020 | - | -$6.28 M(+29.6%) | -$17.51 M(+34.3%) |
| Jun 2020 | - | -$4.84 M(+14.6%) | -$13.04 M(+34.0%) |
| Mar 2020 | - | -$4.23 M(+95.6%) | -$9.73 M(+31.7%) |
| Dec 2019 | -$7.39 M(-23.4%) | -$2.16 M(+19.8%) | -$7.39 M(-4.6%) |
| Sep 2019 | - | -$1.80 M(+17.2%) | -$7.75 M(+28.2%) |
| Jun 2019 | - | -$1.54 M(-18.3%) | -$6.05 M(-27.2%) |
| Mar 2019 | - | -$1.89 M(-25.2%) | -$8.30 M(-19.2%) |
| Dec 2018 | -$9.65 M(-8.3%) | -$2.52 M(+2381.2%) | -$10.28 M(+32.5%) |
| Sep 2018 | - | -$101.60 K(-97.3%) | -$7.76 M(-42.5%) |
| Jun 2018 | - | -$3.80 M(-1.7%) | -$13.50 M(-9.5%) |
| Mar 2018 | - | -$3.86 M(-33.9%) | -$14.92 M(-32.2%) |
| Dec 2017 | -$10.52 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$5.84 M(+11.9%) | -$21.99 M(+4.6%) |
| Jun 2017 | -$21.02 M(+1.0%) | -$5.22 M(+6.3%) | -$21.02 M(-2.7%) |
| Mar 2017 | - | -$4.91 M(-18.5%) | -$21.60 M(+1.2%) |
| Dec 2016 | - | -$6.02 M(+23.5%) | -$21.35 M(+2.4%) |
| Sep 2016 | - | -$4.88 M(-15.8%) | -$20.84 M(+0.2%) |
| Jun 2016 | -$20.81 M(+49.0%) | -$5.79 M(+24.5%) | -$20.81 M(+2.1%) |
| Mar 2016 | - | -$4.65 M(-15.6%) | -$20.39 M(+1.3%) |
| Dec 2015 | - | -$5.51 M(+13.8%) | -$20.13 M(+13.6%) |
| Sep 2015 | - | -$4.84 M(-9.9%) | -$17.72 M(+26.9%) |
| Jun 2015 | -$13.96 M(+734.9%) | -$5.38 M(+22.2%) | -$13.96 M(+47.7%) |
| Mar 2015 | - | -$4.40 M(+41.7%) | -$9.45 M(+71.4%) |
| Dec 2014 | - | -$3.10 M(+186.8%) | -$5.52 M(+114.2%) |
| Sep 2014 | - | -$1.08 M(+24.5%) | -$2.57 M(+53.9%) |
| Jun 2014 | -$1.67 M | -$869.50 K(+89.4%) | -$1.67 M(+108.3%) |
| Mar 2014 | - | -$459.00 K(+181.1%) | -$802.70 K(+133.5%) |
| Dec 2013 | - | -$163.30 K(-9.5%) | -$343.70 K(+90.5%) |
| Sep 2013 | - | -$180.40 K(-110.1%) | -$180.40 K(-103.5%) |
| Dec 2011 | - | $1.78 M(+38.5%) | $5.14 M(+25.3%) |
| Sep 2011 | - | $1.29 M(+18.8%) | $4.11 M(+24.4%) |
| Jun 2011 | - | $1.08 M(+8.5%) | $3.30 M(+22.2%) |
| Mar 2011 | - | $997.00 K(+34.4%) | $2.70 M(+25.6%) |
| Dec 2010 | - | $741.90 K(+54.4%) | $2.15 M(+21.0%) |
| Sep 2010 | - | $480.60 K(-0.1%) | $1.78 M(-74.7%) |
| Jun 2010 | - | $481.10 K(+7.8%) | $7.02 M(-41.1%) |
| Mar 2010 | - | $446.20 K(+20.8%) | $11.91 M(-31.6%) |
| Dec 2009 | - | $369.40 K(-93.5%) | $17.42 M(+2.2%) |
| Sep 2009 | - | $5.72 M(+6.6%) | $17.05 M(+50.5%) |
| Jun 2009 | - | $5.37 M(-9.8%) | $11.33 M(+90.2%) |
| Mar 2009 | - | $5.96 M | $5.96 M |
FAQ
- What is Hepion Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual EBIT year-on-year change?
- What is Hepion Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly EBIT year-on-year change?
- What is Hepion Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM EBIT year-on-year change?
What is Hepion Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of HEPA is -$49.33 M
What is the all time high annual EBIT for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual earnings before interest & taxes is -$1.67 M
What is Hepion Pharmaceuticals annual EBIT year-on-year change?
Over the past year, HEPA annual earnings before interest & taxes has changed by -$4.25 M (-9.43%)
What is Hepion Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of HEPA is -$4.46 M
What is the all time high quarterly EBIT for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly earnings before interest & taxes is $5.96 M
What is Hepion Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, HEPA quarterly earnings before interest & taxes has changed by +$6.21 M (+58.20%)
What is Hepion Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of HEPA is -$30.07 M
What is the all time high TTM EBIT for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM earnings before interest & taxes is $17.42 M
What is Hepion Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, HEPA TTM earnings before interest & taxes has changed by +$19.25 M (+39.03%)